A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection

NCT03369912 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision to withdraw before study started

Conditions

HCMV Infection

Interventions

BIOLOGICAL: CSJ148
OTHER: Placebo

Sponsor

Novartis Pharmaceuticals